Medicinal products (non-steroidal anti-inflammatory compounds) for the treatment of chronic disorders

We have adopted this International Scientific Guideline - 3CC17a

Last updated

15 January 2025

About this guideline

Overseas effective date: August 1987

Categories: Clinical efficacy and safety | Rheumatology / musculoskeletal system

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types